(Q37889116)

24 August 2017

1 reference

title

How to make better use of thrombolytic therapy in acute ischemic stroke (English)

1 reference

24 August 2017

1 reference

1

Geoffrey A Donnan

1 reference

24 August 2017

Stephen M Davis

2

1 reference

24 August 2017

Mark W Parsons

3

1 reference

24 August 2017

Henry Ma

4

1 reference

24 August 2017

Helen M Dewey

5

1 reference

24 August 2017

David W Howells

6

1 reference

24 August 2017

language of work or name

English

0 references

publication date

14 June 2011

1 reference

24 August 2017

published in

Nature Reviews Neurology

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

400-409

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2011.89

24 August 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Do stroke units save lives?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

A systematic review of barriers to delivery of thrombolysis for acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

A graphic reanalysis of the NINDS Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Wake-up stroke: clinical and neuroimaging characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Hemorrhage in the Interventional Management of Stroke study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Methodology of the Interventional Management of Stroke III Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Penumbral selection of patients for trials of acute stroke therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Penumbral mismatch is underestimated using standard volumetric methods and this is exacerbated with time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Fragmentation of the classical magnetic resonance mismatch "penumbral" pattern with time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Visual assessment of perfusion-diffusion mismatch is inadequate to select patients for thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Initial experience with the Penumbra Stroke System for recanalization of large vessel occlusions in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Liver and kidney preservation by perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Alternative pharmacological interventions that limit myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

A pilot study of normobaric oxygen therapy in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Hypothermia for Stroke: call to action 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Management of thrombolysis-associated symptomatic intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Quantitative measurement of cerebral blood flow by (99m)Tc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Invited article: searching for oracles? Blood biomarkers in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Future demographic trends decrease the proportion of ischemic stroke patients receiving thrombolytic therapy: a call to set-up therapeutic studies in the very old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

The application of mass-spectrometry-based protein biomarker discovery to theragnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Extension of the thrombolytic time window with minocycline in experimental stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Comparison of outcomes following thrombolytic therapy among patients with prior stroke and diabetes in the Virtual International Stroke Trials Archive (VISTA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Stroke and thrombolysis in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

The evolving role of helicopter emergency medical services in the transfer of stroke patients to specialized centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Improvement in stroke quality management by an educational programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Introduction of portable computed tomography scanners, in the treatment of acute stroke patients via telemedicine in remote communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

The rural Prehospital Acute Stroke Triage (PAST) trial protocol: a controlled trial for rapid facilitated transport of rural acute stroke patients to a regional stroke centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Impact of acute stroke team emergency calls on in-hospital delays in acute stroke care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Intra-arterial thrombolysis in acute ischemic stroke: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

How well does ASPECTS predict the outcome of acute stroke treated with IV tPA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Stroke Symptoms and the Decision to Call for an Ambulance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

The Impact of Ambulance Practice on Acute Stroke Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Thrombolysis for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

National US Estimates of Recombinant Tissue Plasminogen Activator Use

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

TPA use for stroke in the Registry of the Canadian Stroke Network.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Mechanical thrombectomy with the Penumbra recanalization device in acute ischemic stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

The Interventional Management of Stroke (IMS) II Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Enhancement of fibrinolysis with 40-kHz ultrasound

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Third International Stroke Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Early blood-brain barrier disruption in human focal brain ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Discriminative capacity of biomarkers for acute stroke in the emergency department

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Clinical application of blood biomarkers in cerebrovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Bringing the hospital to the patient: first treatment of stroke patients at the emergency site

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Introduction of an acute stroke team: an effective approach to hasten assessment and management of stroke in the emergency department

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.89

A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).

31 March 2020

1 reference

12 December 2020

Improving access to acute stroke therapies: a controlled trial of organised pre-hospital and emergency care

1 reference

12 December 2020

The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center.

1 reference

12 December 2020

Outcome after stroke upon awakening.

1 reference

12 December 2020

Characterization of ultrasound-potentiated fibrinolysis in vitro

1 reference

12 December 2020

Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little

1 reference

12 December 2020

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group

1 reference

12 December 2020

Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial

1 reference

12 December 2020

Blood biomarkers to guide stroke thrombolysis.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEUROL.2011.89

1 reference

Dimensions Publication ID

24 August 2017

1030641579

0 references

1 reference